v3.26.1
Significant Accounting Policies (Details)
12 Months Ended
Jun. 30, 2026
USD ($)
Segments
shares
Jun. 30, 2025
USD ($)
shares
Significant Accounting Policies [Line Items]    
Uninsured cash balance $ 1,800,000  
Reportable segment (in Segments) | Segments 1  
Operating segments (in Segments) | Segments 1  
Estimated useful life 18 years  
Intangible asset $ 1,457,926
Held for sale equipment 20,000  
Carrying amount 209,225  
Impairment of fixed assets 189,225 0
Loss on disposal of equipment 7,136 0
Impairment loss $ 189,225
Computer Equipment [Member]    
Significant Accounting Policies [Line Items]    
Property, plant, and equipment, useful life 5 years  
Lab Equipment [Member] | Minimum [Member]    
Significant Accounting Policies [Line Items]    
Property, plant, and equipment, useful life 6 years  
Lab Equipment [Member] | Maximum [Member]    
Significant Accounting Policies [Line Items]    
Property, plant, and equipment, useful life 10 years  
Biogen Sciences Inc [Member]    
Significant Accounting Policies [Line Items]    
Impairment charge $ 579,093  
BayMedica Inc. [Member]    
Significant Accounting Policies [Line Items]    
Impairment charge 878,833  
Money Market Funds [Member]    
Significant Accounting Policies [Line Items]    
Cash equivalents 0 $ 4,600,000
BayMedica [Member]    
Significant Accounting Policies [Line Items]    
Severance costs 555,000  
Employee related costs $ 120,000  
Pre-Funded Warrants [Member]    
Significant Accounting Policies [Line Items]    
Antidilutive shares (in Shares) | shares 0 1,952,363